Pharmacist-Led Optimization of High-Alert Medications in Critical Care Settings
DOI:
https://doi.org/10.22399/ijcesen.4484Keywords:
Pharmacist-led optimization, high-alert medications, critical care settings, patient safety, medication managementAbstract
Pharmacist-led optimization of high-alert medications in critical care settings is a crucial component of patient safety and medication management. High-alert medications, which carry a higher risk of causing significant harm if used improperly, require diligent oversight to ensure their safe administration. Pharmacists play a vital role in this process, utilizing their specialized knowledge to assess medication appropriateness, monitor dosing regimens, and identify potential drug interactions. By collaborating closely with healthcare teams, pharmacists can implement evidence-based protocols and recommendations that enhance patient outcomes. Their involvement can lead to the reduction of adverse drug events, streamlined medication reconciliation practices, and improved therapeutic management for critically ill patients. In addition to clinical expertise, pharmacist-led initiatives often include ongoing education and training for healthcare providers about the safe use of high-alert medications. This education encompasses various facets, including understanding the pharmacodynamics and pharmacokinetics of these medications, recognizing the signs of toxicity or therapeutic failure, and employing strategies to mitigate associated risks. By fostering a culture of safety and continuous learning, pharmacists empower the healthcare team to address the complexities of medication management in critical care environments. Ultimately, the integration of pharmacists into critical care teams not only enhances medication safety but also contributes to the overall quality of care provided to vulnerable patient populations.
References
1. Schiff GD, Volk LA, Volodarskaya M, et al. Screening for medication errors using an outlier detection system. Journal of the American Medical Informatics Association. 2017;24(2):281–287.
2. Kanjanarat P, Winterstein AG, Johns TE, Hatton RC, Gonzalez-Rothi R, Segal R. Nature of preventable adverse drug events in hospitals: a literature review. American Journal of Health-System Pharmacy. 2003;160(17):1750–1759.
3. Lee S, Shin J, Kim HS, et al. Hybrid method incorporating a rule-based approach and deep learning for prescription error prediction. Drug Safety. 2022;45(1):27–35.
4. Helmons PJ, Suijkerbuijk BO, Nannan Panday PV, Kosterink JGW. Drug-drug interaction checking assisted by clinical decision support: a return on investment analysis. Journal of the American Medical Informatics Association. 2015;22(4):764–772.
5. Beaudoin M, Kabanza F, Nault V, Valiquette L. Evaluation of a machine learning capability for a clinical decision support system to enhance antimicrobial stewardship programs. Artificial Intelligence in Medicine. 2016;68:29–36.
6. Lghoul-Oulad Saïd F, Hek K, Flinterman LE, et al. Prevalence and incidence rate of hospital admissions related to medication between 2008 and 2013 in The Netherlands. Pharmacoepidemiology and Drug Safety. 2020;29(12):1659–1668.
7. Eppenga WL, Derijks HJ, Conemans JMH, Hermens WAJJ, Wensing M, De Smet PAGM. Comparison of a basic and an advanced pharmacotherapy-related clinical decision support system in a hospital care setting in The Netherlands. Journal of the American Medical Informatics Association. 2012;19(1):66–71.
8. Sutton RT, Pincock D, Baumgart DC, Sadowski DC, Fedorak RN, Kroeker KI. An overview of clinical decision support systems: benefits, risks, and strategies for success. NPJ Digital Medicine. 2020;3:17.
9. de Wit HAJM, Mestres Gonzalvo C, Cardenas J, et al. Evaluation of clinical rules in a standalone pharmacy based clinical decision support system for hospitalized and nursing home patients. International Journal of Medical Informatics. 2015;84(6):396–405.
10. Jiang F, Jiang Y, Zhi H, et al. Artificial intelligence in healthcare: past, present and future. Stroke and Vascular Neurology. 2017;2(4):230–243.
11. Thomsen LA, Winterstein AG, Søndergaard B, Haugbølle LS, Melander A. Systematic review of the incidence and characteristics of preventable adverse drug events in ambulatory care. Annals of Pharmacotherapy. 2007;41(9):1411–1426.
12. Graafsma J, Murphy RM, Klopotowska JE, et al. The use of artificial intelligence to improve medication-related clinical decision support systems: a scoping review protocol. Open Science Framework. 2023.
13. Oehring R, Ramasetti N, Ng S, et al. Use and accuracy of decision support systems using artificial intelligence for tumor diseases: a systematic review and meta-analysis. Frontiers in Oncology. 2023;13:1224347.
14. van der Sijs H, Aarts J, van Gelder T, Berg M, Vulto A. Turning off frequently overridden drug alerts: limited opportunities for doing it safely. Journal of the American Medical Informatics Association. 2008;15(4):439–448.
15. Laatikainen O, Miettunen J, Sneck S, Lehtiniemi H, Tenhunen O, Turpeinen M. The prevalence of medication-related adverse events in inpatients-a systematic review and meta-analysis. European Journal of Clinical Pharmacology. 2017;73(12):1539–1549.
16. Wasylewicz ATM, van de Burgt BWM, Manten T, et al. Contextualized drug-drug interaction management improves clinical utility compared with basic drug-drug interaction management in hospitalized patients. Clinical Pharmacology & Therapeutics. 2022;112(2):382–390.
17. Machoy ME, Szyszka-Sommerfeld L, Vegh A, Gedrange T, Woźniak K. The ways of using machine learning in dentistry. Advances in Clinical and Experimental Medicine. 2020;29(3):375–384.
18. Bakker T, Klopotowska JE, Dongelmans DA, et al. The effect of computerised decision support alerts tailored to intensive care on the administration of high-risk drug combinations, and their monitoring: a cluster randomised stepped-wedge trial. The Lancet. 2024;403(10425):439–449.
19. Bates DW, Levine DM, Salmasian H, et al. The safety of inpatient health care. The New England Journal of Medicine. 2023;388(2):142–153.
20. Wang Z, Nayfeh T, Tetzlaff J, O'Blenis P, Murad MH. Error rates of human reviewers during abstract screening in systematic reviews. PLoS One. 2020;15(1):e0227742.
21. Van Dort BA, Zheng WY, Sundar V, Baysari MT. Optimizing clinical decision support alerts in electronic medical records: a systematic review of reported strategies adopted by hospitals. Journal of the American Medical Informatics Association. 2021;28(1):177–183.
22. Poly TN, Islam MM, Yang H, Li YJ. Appropriateness of overridden alerts in computerized physician order entry: systematic review. JMIR Medical Informatics. 2020;8(7):e15653.
23. Kawazoe Y, Miyo K, Kurahashi I, Sakurai R, Ohe K. Prediction-based threshold for medication alert. Studies in Health Technology and Informatics. 2013;192:229–233.
24. ASReview LAB Developers. ASREview LAB—a tool for AI-assisted systematic review (v1.5). Zenodo. 2024.
25. Wasylewicz ATM, Scheepers-Hoeks AMJW. Clinical decision support systems. In: Kubben P, Dumontier M, Dekker A, eds. Fundamentals of Clinical Data Science. 2019:153–169.
26. Poly TN, Islam MM, Muhtar MS, Yang H, Nguyen PAA, Li YJ. Machine learning approach to reduce alert fatigue using a disease medication-related clinical decision support system: model development and validation. JMIR Medical Informatics. 2020;8(11):e19489.
27. van der Sijs H, Aarts J, Vulto A, Berg M. Overriding of drug safety alerts in computerized physician order entry. Journal of the American Medical Informatics Association. 2006;13(2):138–147.
28. Leendertse AJ, Egberts ACG, Stoker LJ, van den Bemt PMLA. Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Archives of Internal Medicine. 2008;168(17):1890–1896.
29. Peters MDJ, Godfrey CM, Khalil H, McInerney P, Parker D, Soares CB. Guidance for conducting systematic scoping reviews. International Journal of Evidence-Based Healthcare. 2015;13(3):141–146.
30. van de Schoot R, de Bruin J, Schram R, et al. An open source machine learning framework for efficient and transparent systematic reviews. Nature Machine Intelligence. 2021;3(2):125–133.
31. Hogue S-C, Chen F, Brassard G, et al. Pharmacists' perceptions of a machine learning model for the identification of atypical medication orders. Journal of the American Medical Informatics Association. 2021;28(8):1712–1718.
32. Balestra M, Chen J, Iturrate E, Aphinyanaphongs Y, Nov O. Predicting inpatient pharmacy order interventions using provider action data. JAMIA Open. 2021;4(3):ooab083.
33. Segal G, Segev A, Brom A, Lifshitz Y, Wasserstrum Y, Zimlichman E. Reducing drug prescription errors and adverse drug events by application of a probabilistic, machine-learning based clinical decision support system in an inpatient setting. Journal of the American Medical Informatics Association. 2019;26(12):1560–1565.
34. Liu S, Kawamoto K, Del Fiol G, et al. The potential for leveraging machine learning to filter medication alerts. Journal of the American Medical Informatics Association. 2022;29(5):891–899.
35. Bohr A, Memarzadeh K. Chapter 2 - The rise of artificial intelligence in healthcare applications. In: Bohr A, Memarzadeh K, eds. Artificial Intelligence in Healthcare. Academic Press; 2020:25–60.
36. Bates DW, Larizgoitia I, Prasopa-Plaizier N, Jha AK. Global priorities for patient safety research. BMJ. 2009;338:b1775.
37. Ledger TS, Brooke-Cowden K, Coiera E. Post-implementation optimization of medication alerts in hospital computerized provider order entry systems: a scoping review. Journal of the American Medical Informatics Association. 2023;30(12):2064–2071.
38. Warlé-van Herwaarden MF, Kramers C, Sturkenboom MC, van den Bemt PMLA, De Smet PAGM. Targeting outpatient drug safety: recommendations of the Dutch HARM-Wrestling Task Force. Drug Safety. 2012;35(3):245–259.
39. Peiffer-Smadja N, Rawson TM, Ahmad R, et al. Machine learning for clinical decision support in infectious diseases: a narrative review of current applications. Clinical Microbiology and Infection. 2020;26(5):584–595.
40. Reese TJ, Kawamoto K, Fiol GD, et al. When an alert is not an alert: a pilot study to characterize behavior and cognition associated with medication alerts. AMIA Annual Symposium Proceedings. 2018;2018:1488–1497.
41. Corny J, Rajkumar A, Martin O, et al. A machine learning-based clinical decision support system to identify prescriptions with a high risk of medication error. Journal of the American Medical Informatics Association. 2020;27(11):1688–1694.
42. Liu X, Cruz Rivera S, Moher D, Calvert MJ, Denniston AK. Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension. Nature Medicine. 2020;26(9):1364–1374.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 International Journal of Computational and Experimental Science and Engineering

This work is licensed under a Creative Commons Attribution 4.0 International License.